{"schema_version":"secwatch.filing_event.v1","accession":"0000920148-23-000032","form_type":"8-K","ticker":"LH","cik":"0000920148","company_name":"LABCORP HOLDINGS INC.","filed_at":"2023-05-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:42.809749+00:00","generated_at":"2026-06-15T23:51:48.276447+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Labcorp appoints Brian Caveney as President Early Development & Chief Medical Officer amid spin-off prep","bullets":["Brian J. Caveney appointed Executive Vice President, President Early Development & Chief Medical and Scientific Officer effective May 1, 2023.","His base salary increased to $650,000 as part of the organizational restructuring for the planned spin-off.","He will receive RSU and performance share awards each valued at $67,000, plus a stock option award valued at $201,000 on May 5, 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0000920148-23-000032","json":"https://secwatch.observer/filing/0000920148-23-000032.json","markdown":"https://secwatch.observer/filing/0000920148-23-000032.md","text":"https://secwatch.observer/filing/0000920148-23-000032.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/920148/000092014823000032/0000920148-23-000032-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/920148/000092014823000032/lh-20230501.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-15T23:51:48.276447+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"53845b841a","claim":"Brian J. Caveney was appointed as Executive Vice President, President Early Development & Chief Medical and Scientific Officer at LABCORP HOLDINGS INC..","evidence_excerpt":"Labcorp announced that Brian J. Caveney, the current Executive Vice President, President, Diagnostics and Chief Medical Officer of Labcorp, a named executive officer, has been appointed to the position of Executive Vice President, President Early Development & Chief Medical and Scientific Officer, effective May 1, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/920148/000092014823000032/0000920148-23-000032-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Executive Vice President, President Early Development & Chief Medical and Scientific Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}